Abstract
For a long time, empirical observation and popular wisdom have suggested a tight link between neurological disease and cardiac complications, yet only in recent years has the improvement of knowledge supported by new technical approaches allowed a more detailed insight in the mechanisms underlying such connection. Both acute and chronic brain diseases may have relevant impacts on heart eliciting arrhythmias as well as myocardial ischemia, which might have catastrophic consequences. In this chapter, we will illustrate the most frequent acute and chronic neurological diseases in which clinical relevant cardiac complications manifest. In the first section, the physiological basis of the complex and intriguing relationship between heart and brain under physiological conditions will be discussed. Thereafter, we will focus on cerebrovascular accidents, along with traumatic brain and spinal cord injury, epilepsy, immune-mediated polyradiculoneuropathies, and myasthenia gravis, which represent the most frequent categories for acute neurocardiac complications. In the second part of this chapter, recent additions to our knowledge on dysautonomia and myocardial denervation observed in neurological degenerative disease will be illustrated. A better understanding of the intimate connections between brain and heart is the basis for a more affective prevention of cardiac complications in patients with neurological disease and customized therapeutical interventions of neurological diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Taggart P, Critchley H, Lambiase PD. Heart-brain interactions in cardiac arrhythmia. Heart. 2011;97(9):698–708.
Schwartz B. The world of thought in ancient China. Cambridge: Harvard University Press; 1985.
Samuels MA. ‘Voodoo’ death revisited: the modern lessons of neurocardiology. Cleve Clin J Med. 2007;74 Suppl 1:S8–16.
Leor J, Poole WK, Kloner RA. Sudden cardiac death triggered by an earthquake. N Engl J Med. 1996;334(7):413–9.
Hua F, et al. c-Fos expression in rat brain stem and spinal cord in response to activation of cardiac ischemia-sensitive afferent neurons and electrostimulatory modulation. Am J Physiol Heart Circ Physiol. 2004;287:H2728–38.
Gray MA, Taggart P, Sutton PM, Groves D, Holdright DR, Bradbury D, Brull D, Critchley HD. A cortical potential reflecting cardiac function. Proc Natl Acad Sci U S A. 2007;104(16):6818–23.
Hagemann D, Waldstein SR, Thayer JF. Central and autonomic nervous system integration in emotion. Brain Cogn. 2003;52(1):79–87.
Natelson BH. Neurocardiology. An interdisciplinary area for the 80s. Arch Neurol. 1985;42(2):178–84. Review.
Davis AM, Natelson BH. Brain-heart interactions. The neurocardiology of arrhythmia and sudden cardiac death. Tex Heart Inst J. 1993;20(3):158–69. Review.
Benarroch E. Chapter 4. In: Robertson D, et al., editors. Primer on autonomic nervous system. 2nd ed. Philadelphia: Elsevier; 2004.
Toivonen L, Helenius K, Viitasalo M. Electrocardiographic repolarization during stress from awakening on alarm call. J Am Coll Cardiol. 1997;30:774–9.
Oppenheimer S. Cerebrogenic cardiac arrhythmias: cortical lateralization and clinical significance. Clin Auton Res. 2006;16:6–11.
Critchley HD, Wiens S, Rotshtein P, Ohman A, Dolan RJ. Neural systems supporting interoceptive awareness. Nat Neurosci. 2004;7(2):189–95.
Critchley HD, Taggart P, Sutton PM, Holdright DR, Batchvarov V, Hnatkova K, Malik M, Dolan RJ. Mental stress and sudden cardiac death: asymmetric midbrain activity as a linking mechanism. Brain. 2005;128(Pt 1):75–85.
Lampert R, Jain D, Burg MM, Batsford WP, McPherson CA. Destabilizing effects of mental stress on ventricular arrhythmias in patients with implantable cardioverter-defibrillators. Circulation. 2000;101(2):158–64.
Green AL, Paterson DJ. Identification of neurocircuitry controlling cardiovascular function in humans using functional neurosurgery: implications for exercise control. Exp Physiol. 2008;93(9):1022–8.
Green AL, Wang S, Owen SL, Paterson DJ, Xie K, Liu X, Bain PG, Stein JF, Aziz TZ. Functional Neurosurgery Resident Award: controlling the cardiovascular system with deep brain stimulation. Clin Neurosurg. 2006;53:316–23.
Dote K, Sato KT, et al. Myocardial stunning due to simultaneous multi vessel coronary spasms: a review of 5 cases. J Cardiol. 1991;21:203–14.
Wittstein I, Thiemann DR, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352:539–48.
Sharkey S, Lesser J, et al. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation. 2005;111:472–9.
Hessel E. The brain and the heart. Anesth Analg. 2006;103(3):522–6.
Desmet W, Dynamic LV. Obstruction in apical ballooning syndrome: the chicken or the egg? Eur J Echocardiogr. 2006;7:1–3.
Merli E, Sutcliffe S, et al. TakoTako-Tsubo cardiomyopathy: new insights into the possible underlying pathophysiology. Eur J Echocardiogr. 2006;7:53.
Oppenheimer SM, Wilson JX, et al. Insular cortex stimulation produces lethal cardiac arrhythmias: a mechanism of sudden death? Brain Res. 1991;550:115–21.
Critchley HD, Corfield DR, et al. Cerebral correlates of autonomic cardiovascular arousal: a functional neuroimaging investigation in humans. J Physiol. 2000;523:259–70.
Kolominsky-Rabas PL, Weber M, et al. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke. 2001;32:2735–40.
Rincon F, Dhamoon M, et al. Stroke location and association with fatal cardiac outcomes. Northern Manhattan Study (NOMAS). Stroke. 2008;39:2425–51.
Grau AJ, Weimar C, et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke. 2001;32(11):2559–66.
Norris JW, Froggatt GM, Hachinski VC. Cardiac arrhythmias in acute stroke. Stroke. 1978;9(4):392–6.
Cheung RTF, Hachinski W. The insula and cerebrogenic sudden death. Arch Neurol. 2000;57:1685–8.
Touzé E, Varenne O, et al. Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis. Stroke. 2005;36(12):2748–55. Review.
van Bree MD, Roos YB, et al. Prevalence and characterization of ECG abnormalities after intracerebral hemorrhage. Neurocrit Care. 2010;12(1):50–5.
Hravanak M, Frangiskakis M, et al. Elevated cardiac troponin I and relationship to persistence of electrocardiographic and echocardiographic abnormalities after aneurysmal subarachnoid hemorrhage. Stroke. 2009;40:3478–84.
Naidech AN, Kreiter KT, et al. Cardiac troponin elevation, cardiovascular morbidity and outcome after subarachnoid hemorrhage. Circulation. 2005;112:2851–6.
Banki N, Kopelnik A, et al. Acute neurocardiogenic injury after subarachnoid hemorrhage. Circulation. 2005;112:3314–9.
Zaroff JG, Pawlikoska L, et al. Adrenoceptor polymorphisms and the risk of cardiac injury and dysfunction after subarachnoid hemorrhage. Stroke. 2006;37:1680–5.
Tung PP, Olmsted E, et al. Plasma B-type natriuretic peptide levels are associated with early cardiac dysfunction after subarachnoid hemorrhage. Stroke. 2005;36:1567–71.
Lee V, Oh JK, et al. Mechanisms in neurogenic stress cardiomyopathy after aneurismal subarachnoid hemorrhage. Neurocrit Care. 2006;05:243–9.
Naredi S, Lambert G, et al. Increased sympathetic nervous activity in patients with non-traumatic subarachnoid hemorrhage. Stroke. 2000;31:901–6.
Manno EM, Pfeifer EA, et al. Cardiac pathology in patients with status epilepticus. Neurocrit Care. 2005;2:231.
Cebelin MS, Hirsch CS. Human stress cardiomyopathy. Myocardial lesions in victims of homicidal assaults without internal injuries. Hum Pathol. 1980;11:123–32.
Dimant J, Grob D. Electrocardiographic changes and myocardial damage in patients with acute cerebrovascular accidents. Stroke. 1977;8(4):448–55.
Oppenheimer SM, Gelb A, Girvin JP, Hachinski VC. Cardiovascular effects of human insular cortex stimulation. Neurology. 1992;42(9):1727–32.
Cechetto DF, Wilson JX, Smith KE, Wolski D, Silver MD, Hachinski VC. Autonomic and myocardial changes in middle cerebral artery occlusion: stroke models in the rat. Brain Res. 1989;502(2):296–305.
Hachinski VC, Smith KE, Silver MD, Gibson CJ, Ciriello J. Acute myocardial and plasma catecholamine changes in experimental stroke. Stroke. 1986;17(3):387–90.
Nolte J. The human brain. 4th ed. St. Louis: Mosby; 1999.
Cereda C, Ghika J, Maeder P, Bogousslavsky J. Strokes restricted to the insular cortex. Neurology. 2002;59(12):1950–5.
Augustine JR. Circuitry and functional aspects of the insular lobe in primates including humans. Brain Res Brain Res Rev. 1996;22(3):229–44. Review.
Critchley HD. The human cortex responds to an interoceptive challenge. Proc Natl Acad Sci U S A. 2004;101(17):6333–4.
Türe U, Yasargil MG, Al-Mefty O, Yasargil DCH. Arteries of insula. J Neurosurg. 2000;92:676–87.
Sander D, Winbeck K, Klingelhöfer J, Etgen T, Conrad B. Prognostic relevance of pathological sympathetic activation after acute thromboembolic stroke. Neurology. 2001;57(5):833–8.
Ay H, Koroshetz WJ, et al. Neuroanatomic correlates of stroke-related myocardial injury. Neurology. 2006;66:1325–9.
Colivicchi F, Bassi A, Santini M, Caltagirone C. Prognostic implications of right-sided insular damage, cardiac autonomic derangement, and arrhythmias after acute ischemic stroke. Stroke. 2005;36(8):1710–5.
Tokgosoglu SL, Batur MK, et al. Effects of stroke localization on cardiac autonomic balance and sudden death. Stroke. 1999;30:1307–11.
Christensen H, Boysen G, Christensen AF, Johannesen HH. Insular lesions, ECG abnormalities, and outcome in acute stroke. J Neurol Neurosurg Psychiatry. 2005;76(2):269–71.
Laowattana S, Zeger SL, Lima JA, Goodman SN, Wittstein IS, Oppenheimer SM. Left insular stroke is associated with adverse cardiac outcome. Neurology. 2006;66(4):477–83.
Fink JN, Frampton CM, Lyden P, Lees KR, Virtual international stroke trials archive investigators. Does hemispheric lateralization influence functional and cardiovascular outcomes after stroke?: an analysis of placebo-treated patients from prospective acute stroke trials. Stroke. 2008;39(12):3335–40.
Urbinati S, Di Pasquale G, Andreoli A, Lusa AM, Ruffini M, Lanzino G, Pinelli G. Frequency and prognostic significance of silent coronary artery disease in patients with cerebral ischemia undergoing carotid endarterectomy. Am J Cardiol. 1992;69(14):1166–70.
Gongora-Rivera F, Labreuche J, Jaramillo A, Steg PG, Hauw JJ, Amarenco P. Autopsy prevalence of coronary atherosclerosis in patients with fatal stroke. Stroke. 2007;38(4):1203–10.
Lavy S, Yaar I, Melamed E, Stern S. The effect of acute stroke on cardiac functions as observed in an intensive stroke care unit. Stroke. 1974;5(6):775–80.
Goldstein D. The electrocardiogram in stroke: relationship to pathophysiological type and comparison with prior tracings. Stroke. 1979;10:253–9.
Rem JA, Hachinski VC, Boughner DR, Barnett HJ. Value of cardiac monitoring and echocardiography in TIA and stroke patients. Stroke. 1985;16(6):950–6.
Orlandi G, Fanucchi S, Strata G, Pataleo L, Landucci Pellegrini L, Prontera C, Martini A, Murri L. Transient autonomic nervous system dysfunction during hyperacute stroke. Acta Neurol Scand. 2000;102(5):317–21.
Lin HJ, Wolf PA, Benjamin EJ, Belanger AJ, D’Agostino RB. Newly diagnosed atrial fibrillation and acute stroke. The Framingham Study. Stroke. 1995;26(9):1527–30.
Hart RG. Atrial fibrillation and stroke prevention. N Engl J Med. 2003;349(11):1015–6.
Hart RG, Pearce LA, Rothbart RM, McAnulty JH, Asinger RW, Halperin JL. Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol. 2000;35(1):183–7.
Tayal AH, Tian M, Kelly KM, Jones SC, Wright DG, Singh D, Jarouse J, Brillman J, Murali S, Gupta R. Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke. Neurology. 2008;71(21):1696–701.
Paciaroni M, Agnelli G, Caso V, Venti M, Milia P, Silvestrelli G, Parnetti L, Biagini S. Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome. J Thromb Haemost. 2005;3(6):1218–23.
Liao J, Khalid Z, Scallan C, Morillo C, O’Donnell M. Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review. Stroke. 2007;38(11):2935–40.
Dütsch M, Burger M, Dörfler C, Schwab S, Hilz MJ. Cardiovascular autonomic function in poststroke patients. Neurology. 2007;69(24):2249–55.
Di Angelantonio E, Fiorelli M, Toni D, Sacchetti ML, Lorenzano S, Falcou A, Ciarla MV, Suppa M, Bonanni L, Bertazzoni G, Aguglia F, Argentino C. Prognostic significance of admission levels of troponin I in patients with acute ischemic stroke. J Neurol Neurosurg Psychiatry. 2005;76(1):76–81.
Lee SJ, Lee KS, Kim YI, An JY, Kim W, Kim JS. Clinical features of patients with a myocardial infarction during acute management of an ischemic stroke. Neurocrit Care. 2008;9(3):332–7.
Yoshimura S, Toyoda K, Ohara T, Nagasawa H, Ohtani N, Kuwashiro T, Naritomi H, Minematsu K. Takotsubo cardiomyopathy in acute ischemic stroke. Ann Neurol. 2008;64(5):547–54.
Prosser J, MacGregor L, Lees KR, Diener HC, Hacke W, Davis S, VISTA Investigators. Predictors of early cardiac morbidity and mortality after ischemic stroke. Stroke. 2007;38(8):2295–302.
Silver FL, Norris JW, Lewis AJ, Hachinski VC. Early mortality following stroke: a prospective review. Stroke. 1984;15(3):492–6.
Algra A, Gates PC, Fox AJ, Hachinski V, Barnett HJ, North American Symptomatic Carotid Endarterectomy Trial Group. Side of brain infarction and long-term risk of sudden death in patients with symptomatic carotid disease. Stroke. 2003;34(12):2871–5.
Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1991;325(7):445–53.
Kaplan RC, Tirschwell DL, Longstreth Jr WT, Manolio TA, Heckbert SR, Lefkowitz D, El-Saed A, Psaty BM. Vascular events, mortality, and preventive therapy following ischemic stroke in the elderly. Neurology. 2005;65(6):835–42.
Adams Jr HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF, American Heart Association, American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38(5):1655–711; Stroke. 2007; 38(9):e96.
Fang CX, Wu S, Ren J. Intracerebral hemorrhage elicits aberration in cardiomyocyte contractile function and intracellular Ca2+ transients. Stroke. 2006;37(7):1875–82.
Maramattom BV, Manno EM, Fulgham JR, Jaffe AS, Wijdicks EF. Clinical importance of cardiac troponin release and cardiac abnormalities in patients with supratentorial cerebral hemorrhages. Mayo Clin Proc. 2006;81(2):192–6.
Hays A, Diringer MN. Elevated troponin levels are associated with higher mortality following intracerebral hemorrhage. Neurology. 2006;66(9):1330–4.
Banuelos PA, Temes R, Lee VH. Neurogenic stunned myocardium associated with reversible posterior leukoencephalopathy syndrome. Neurocrit Care. 2008;9(1):108–11.
Papanikolaou J, Tsirantonaki M, Koukoulitsios G, Papageorgiou D, Mandila C, Karakitsos D, Karabinis A. Reversible posterior leukoencephalopathy syndrome and tako-tsubo cardiomyopathy: the role of echocardiographic monitoring in the ICU. Hellenic J Cardiol. 2009;50(5):436–8.
Layon J, Friedman WA, Gabrielli A, editors. Textbook of neurointensive care. Philadelphia: WB Saunders; 2003. Chapter 8.
Blackman JA, Patrick PD, Buck ML, Rust Jr RS. Paroxysmal autonomic instability with dystonia after brain injury. Arch Neurol. 2004;61(3):321–8. Review.
Baguley IJ, Heriseanu RE, Cameron ID, Nott MT, Slewa-Younan S. A critical review of the pathophysiology of dysautonomia following traumatic brain injury. Neurocrit Care. 2008;8(2):293–300. Review.
Singleton RH, Adelson PD. Chapter 3: Diffuse axonal injury and dysautonomia. In: Bhardwa JA, Ellegala DB, Kirsch JR, editors. Acute brain and spinal cord injury: evolving paradigms and management. New York: Informa Healthcare; 2008.
Boeve BF, Wijdicks EF, Benarroch EE, Schmidt KD. Paroxysmal sympathetic storms (“diencephalic seizures”) after severe diffuse axonal head injury. Mayo Clin Proc. 1998;73(2):148–52.
Kishner S, et al. Post head injury autonomic complications. 2008. http://emedicine.medscape.com/article/325994-overview#showall
Baguley IJ, Heriseanu RE, Felmingham KL, Cameron ID. Dysautonomia and heart rate variability following severe traumatic brain injury. Brain Inj. 2006;20(4):437–44 (Abstract).
Bourdages M, et al. Cardiac arrhythmias associated with severe traumatic brain injury and hypothermia therapy. Pediatr Crit Care Med. 2010;11(3):439–41.
Bourdages M, Bigras JL, Farrell CA, Hutchison JS, Lacroix J, Canadian Critical Care Trials Group. Cardiac arrhythmias associated with severe traumatic brain injury and hypothermia therapy. Pediatr Crit Care Med. 2010;11(3):408–14.
Furlan JC, Fehlings MG. Cardiovascular complications after acute spinal cord injury: pathophysiology, diagnosis, and management. Neurosurg Focus. 2008;25(5):E13. Review.
Rowland JW, Hawryluk GW, Kwon B, Fehlings MG. Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. Neurosurg Focus. 2008;25(5):E2. Review.
Garshick E, Kelley A, Cohen SA, Garrison A, Tun CG, Gagnon D, Brown R. A prospective assessment of mortality in chronic spinal cord injury. Spinal Cord. 2005;43(7):408–16.
Stein DM, Menaker J, McQuillan K, Handley C, Aarabi B, Scalea TM. Risk factors for organ dysfunction and failure in patients with acute traumatic cervical spinal cord injury. Neurocrit Care. 2010;13(1):29–39.
Bunten DC, Warner AL, Brunnemann SR, Segal JL. Heart rate variability is altered following spinal cord injury. Clin Auton Res. 1998;8(6):329–34.
Furlan JC, Fehlings MG. The impact of age on mortality, impairment, and disability among adults with acute traumatic spinal cord injury. J Neurotrauma. 2009;26(10):1707–17.
Grigorean VT, Sandu AM, Popescu M, Iacobini MA, Stoian R, Neascu C, Strambu V, Popa F. Cardiac dysfunctions following spinal cord injury. J Med Life. 2009;2(2):133–45. Review.
Mathias CJ. Chapter 81: Autonomic disturbances in spinal cord injuries. In: Robertson D, editor. Primer on the autonomic nervous system. 2nd ed. Philadelphia: Elsevier; 2004.
Asahina M, Kuwabara S, et al. Autonomic function in demyelinating and axonal subtypes of Guillain Barrè syndrome. Acta Neurol Scand. 2002;105(1):44–50.
Dionne A, Nicolle MW, Hahn AF. Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy. Muscle Nerve. 2010;41:202–7.
Mukerji S, Aloka F, et al. Cardiovascular complications of the Guillain-Barrè syndrome. Am J Cardiol. 2009;104:1452–5.
Pfeiffer G, Schiller H, et al. Indicators of dysautonomia in sever Guillain Barrè syndrome. J Neurol. 1999;246:1015–22.
Greenland P, Griggs RC. Arrhythmic complications in the Guillain Barrè syndrome. Arch Intern Med. 1980;40:1053–5.
Hodson AK, Hurwitz BJ, et al. Dysautonomia in Guillain-Barrè syndrome with dorsal root ganglioneuropathy, wallerian degeneration and fatal myocarditis. Ann Neurol. 1984;15(1):88–95.
Finkelstein JS, Melek BH. Guillain-Barrè syndrome as a cause of reversible cardiomyopathy. Tex Heart Inst J. 2006;33:57–9.
Iga K, Himura Y, et al. Reversible left ventricular dysfunction associated with Guillain Barrè syndrome-an expression of catecholamine cardiotoxicity? Jpn Circ J. 1995;59:236–40.
Gibson TC. The heart in myasthenia gravis. Am Heart J. 1975;90(3):389–96.
Hofstad H, Ohm OJ, Mork SJ, Aarli JA. Heart disease in myasthenia gravis. Acta Neurol Scand. 1984;70(3):176–84.
Suzuki S, Utsugisawa K, et al. Autoimmune targets of heart and skeletal muscles in myasthenia gravis. Arch Neurol. 2009;66(11):1334–8.
Beydoun SR, Wang JT, et al. Emotional stress as a trigger of myasthenic crisis and concomitant takotsubo cardiomyopathy: a case report. J Med Case Reports. 2010;4:393.
Bradley WG. Polymyositis: an overdiagnosed entity. Neurology. 2004;63(2):402.
Gottdiener JS, Sherber HS, et al. Cardiac manifestations in polymyositis. Am J Cardiol. 1978;41(7):1141–9.
Lundberg IE. The heart in dermatomyositis and polymyositis. Rheumatology. 2006;45:iv18–21.
Stern R, Godbold JH, et al. ECG abnormalities in polymyositis. Arch Intern Med. 1984;144:2185–9.
Haupt HM, Hutschins GM, et al. The heart and cardiac conduction system in polymyositis-dermatomyositis: a clinicopathologic study of 16 autopsied patients. Am J Cardiol. 1982;50:998–1006.
Rocamora R, Kurthen M, et al. Cardiac asystole in epilepsy: clinical and neurophysiologic features. Epilepsia. 2003;44(2):179–85.
Boggs JG. Mortality associated with status epilepticus. Epilepsy Curr. 2004;4(1):25–7.
Nevander G, Ingvar M, et al. Status epilepticus in well-oxygenated rats causes neuronal necrosis. Ann Neurol. 1985;18:281–90.
De Lorenzo RJ, Towne AR, et al. Status epilepticus in children, adults and the elderly. Epilepsia. 1992;33 suppl 4:S15–25.
Towne AR, Pellock JM, et al. Determinants of mortality in status epilepticus. Epilepsia. 1994;35:27–34.
Boggs JG, Maramarou A, et al. Hemodynamic monitoring prior to and at the time of death in status epilepticus. Epilepsy Res. 1998;31(3):199–209.
Metcalf C, Poelzing S, et al. Status epilepticus induces cardiac myofilament damage and increased susceptibility to arrhythmias in rats. Am J Physiol Heart Circ Physiol. 2009;297:H2120–7.
Lemke DM, Hussain SI, et al. Tako-tsubo cardiomyopathy associated with seizures. Neurocrit Care. 2008;9:112–7.
Legriel S, Bruneel F, et al. Recurrent takotsubo cardiomyopathy triggered by convulsive status epilepticus. Neurocrit Care. 2008;9:118–21.
Shimutzu M, Kagawa A, et al. Neurogenic stunned myocardium associated with status epilepticus and postictal catecholamine surge. Intern Med. 2007;47:269–73.
Nashef L. Sudden unexpected death in epilepsy: terminology and definitions. Epilepsia. 1997;38(suppl11):S6–8.
Tomson T, Walczak T, et al. Sudden unexpected death in epilepsy: a review of incidence and risk factors. Epilepsia. 2005;46 suppl 11:54–61.
Jehi L, Najm IM. Sudden unexpected death in epilepsy: impact, mechanisms and prevention. Cleve Clin J Med. 2008;75 suppl 2:s66–70.
Goldstein DS. Cardiac denervation in patients with Parkinson disease. Cleve Clin J Med. 2007;74 Suppl 1:S91–4.
Walter BL. Cardiovascular autonomic dysfunction in patients with movement disorders. Cleve Clin J Med. 2008;75 Suppl 2:S54–8.
Goldstein DS. Neuroscience and heart-brain medicine: the year in review. Cleve Clin J Med. 2010;77 Suppl 3:S34–9.
Orimo S, Uchihara T, Nakamura A, Mori F, Kakita A, Wakabayashi K, Takohashi H. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson’s disease. Brain. 2008;131(Pt3):642–50.
Goldstein D. Dysautonomia in Parkinson’s disease: neurocardiological abnormalities. Lancet Neurol. 2003;2:669–76.
Post S, Papetropulos KK. Chapter 5C. In: Halliday G, Barker R, Rowe D, editors. Non dopamine lesions in Parkinson Diseases. Cambridge: Oxford Press; 2010.
Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1999;67(2):189–94.
Yoshita M, Taki J, Yamada M. A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer’s-type and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2001;71(5):583–8.
Nagayama H, Hamamoto M, Ueda M, Nagashima J, Katayama Y. Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2005;76(2):249–51.
Marquié Sayagués M, Da Silva Alves L, Molina-Porcel L, Alcolea Rodríguez D, Sala Matavera I, Sánchez-Saudinós MB, Camacho Martí V, Estorch Cabrera M, Blesa González R, Blesa González R, Gómez-Isla T, Gómez-Isla T, Lleó Bisa A, Lleó Bisa A. (123)I-MIBG myocardial scintigraphy in the diagnosis of Lewy body dementia. Neurologia. 2010;25(7):414.
Camacho V, Marquié M, Lleó A, Alvés L, Artigas C, Flotats A, Duch J, Blesa R, Gómez-Isla T, Carrió I, Estorch M. Cardiac sympathetic impairment parallels nigrostriatal degeneration in probable dementia with Lewy bodies. Q J Nucl Med Mol Imaging. 2011;55(4):476–83.
Valappil RA, Black JE, Broderick MJ, Carrillo O, Frenette E, Sullivan SS, Goldman SM, Tanner CM, Langston JW. Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson’s disease. Mov Disord. 2010;25(14):2296–303.
Goldstein DS, Eldadah BA, Holmes C, Pechnik S, Moak J, Saleem A, Sharabi Y. Neurocirculatory abnormalities in Parkinson disease with orthostatic hypotension: independence from levodopa treatment. Hypertension. 2005;46(6):1333–9.
Iranzo A, Molinuevo JL, Santamaría J, Serradell M, Martí MJ, Valldeoriola F, Tolosa E. Rapid-eye-movement sleep behavior disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol. 2006;5(7):572–7.
Wenning GK, Colosimo C, Geser F, Poewe W. Multiple system atrophy. Lancet Neurol. 2004;3(2):93–103. Erratum in: Lancet Neurol. 2004;3(3):137.
Royall DR. Insular Alzheimer disease pathology and the psychometric correlates of mortality. Cleve Clin J Med. 2008;75 suppl 2:S97–9.
Nakajima K, Yoshita M, et al. Ionidne-123-MIBG sympathetic imaging in Lewy-body diseases and related movement disorders. Q J Nucl Med Mol Imaging. 2008;52:378–87.
Sasaki K, Sakata K, et al. Sequential changes in cardiac structure and function in patients with Duchenne-type muscular dystrophy: a two-dimensional echocardiographic study. Am Heart J. 1998;135:937–44.
Mavrogeni S, Tzelepis G, et al. Cardiac and sternocleidomastoid muscle involvement in Duchenne muscular dystrophy an MRI study. Chest. 2005;127:143–8.
Grubb BP. Clinical practice. Neurocardiogenic syncope. N Engl J Med. 2005;352(10):1004–10.
Freeman R. Clinical practice. Neurogenic orthostatic hypotension. N Engl J Med. 2008;358(6):615–24.
Critchley HD, Mathias CJ, Oliver J, et al. Human cingulated cortex and autonomic control: converging neuroimaging and clinical evidence. Brain. 2003;126:213–2152.
Lim ECH, Lim S-H, Wilder-smith E. Brain seizes, heart ceases: a case of ictal asystole. J Neurol Neurosurg Psychiatry. 2000;69:557–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Iani, C., Montinaro, E., Bonaffini, N., Gaspardone, A. (2013). Cardiac Implications of Neurological Disease. In: Layon, A., Gabrielli, A., Friedman, W. (eds) Textbook of Neurointensive Care. Springer, London. https://doi.org/10.1007/978-1-4471-5226-2_13
Download citation
DOI: https://doi.org/10.1007/978-1-4471-5226-2_13
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-5225-5
Online ISBN: 978-1-4471-5226-2
eBook Packages: MedicineMedicine (R0)